HMFS alleviates diet-induced metabolic impairments in mice by enriching LPC 18:2, which activates GPR119-AMPK signaling to promote hepatic lipid catabolism. These findings provide mechanistic evidence supporting structured lipids as potential nutritional interventions for obesity-related liver disease.
He et al. (Sun,) studied this question.